Search Results - "Chiang, Teresa P.‐Y."

Response to “COVID‐19 in SOT versus non‐SOT” by Avery, Robin K., Chiang, Teresa P.‐Y., Marr, Kieren A., Garonzik‐Wang, Jacqueline, Segev, Dorry L., Massie, Allan B.

Get full text

Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series by Alejo, Jennifer L., Mitchell, Jonathan, Chiang, Teresa P.-Y., Abedon, Aura T., Boyarsky, Brian J., Avery, Robin K., Tobian, Aaron A.R., Levan, Macey L., Massie, Allan B., Garonzik-Wang, Jacqueline M., Segev, Dorry L., Werbel, William A.

“…Supplemental Digital Content is available in the text…”
Get full text

Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19 by Alejo, Jennifer L, Mitchell, Jonathan, Chang, Amy, Chiang, Teresa P. Y, Massie, Allan B, Segev, Dorry L, Makary, Martin A

“…As of Dec 28, 2021, approximately 27% of the US population was unvaccinated against SARS-CoV-2, yet the prevalence of natural immunity remains unknown. Blood…”
Get full text

Letter to the editor: Six‐month antibody kinetics and durability in liver transplant recipients after two doses of SARS‐CoV‐2 mRNA vaccination by Chang, Amy, Strauss, Alexandra T., Alejo, Jennifer L., Chiang, Teresa P.‐Y., Hernandez, Nicole F., Zeiser, Laura B., Boyarsky, Brian J., Avery, Robin K., Tobian, Aaron A. R., Levan, Macey L., Warren, Daniel S., Garonzik‐Wang, Jacqueline M., Massie, Allan B., Werbel, William A., Segev, Dorry L.

“…Anti-spike antibody waning after two doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccination among liver…”
Get full text

Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients by Boyarsky, Brian J., Chiang, Teresa P.-Y., Ou, Michael T., Werbel, William A., Massie, Allan B., Segev, Dorry L., Garonzik-Wang, Jacqueline M.

Get full text

Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept by Ou, Michael T., Boyarsky, Brian J., Chiang, Teresa P.Y., Bae, Sunjae, Werbel, William A., Avery, Robin K., Tobian, Aaron A.R., Massie, Allan B., Segev, Dorry L., Garonzik-Wang, Jacqueline M.

“…BACKGROUNDBelatacept may impair humoral immunity, impacting the effectiveness of SARS-CoV-2 mRNA vaccines in transplant recipients. We investigated…”
Get full text

Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients by Karaba, Andrew H., Kim, Jake D., Chiang, Teresa P-Y., Alejo, Jennifer L., Sitaras, Ioannis, Abedon, Aura T., Eby, Yolanda, Johnston, Trevor Scott, Li, Maggie, Aytenfisu, Tihitina, Hussey, Casey, Jefferis, Alexa, Fortune, Nicole, Abedon, Rivka, Thomas, Letitia, Habtehyimer, Feben, Ruff, Jessica, Warren, Daniel S., Avery, Robin K., Clarke, William A., Pekosz, Andrew, Massie, Allan B., Tobian, Aaron A.R., Segev, Dorry L., Werbel, William A.

“…Neutralizing antibody (nAb) responses are attenuated in solid organ transplant recipients (SOTRs) despite severe acute respiratory syndrome-coronavirus-2…”
Get full text

Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients by Boyarsky, Brian J., Chiang, Teresa P.-Y., Teles, Aura T., Greenberg, Ross S., Krach, Michelle R., Ou, Michael T., Massie, Allan B., Tobian, Aaron A. R., Garonzik-Wang, Jacqueline M., Segev, Dorry L., Werbel, and William A.

Get full text

Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients by Strauss, Alexandra T., Chang, Amy, Alejo, Jennifer L., Chiang, Teresa P.‐Y., Hernandez, Nicole F., Zeiser, Laura B., Boyarsky, Brian J., Avery, Robin K., Tobian, Aaron A. R., Levan, Macey L., Warren, Daniel S., Massie, Allan B., Garonzik‐Wang, Jacqueline M., Segev, Dorry L., Werbel, William A.

Get full text

Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case Series by Chang, Amy, Alejo, Jennifer L., Abedon, Aura T., Mitchell, Jonathan, Chiang, Teresa P.-Y., Boyarsky, Brian J., Avery, Robin K., Tobian, Aaron A.R., Levan, Macey L., Warren, Daniel S., Massie, Allan B., Garonzik-Wang, Jacqueline M., Segev, Dorry L., Werbel, William A.

Get full text

Patient-reported outcomes after Tixagevimab and Cilgavimab pre-exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk by Alejo, Jennifer L, Kim, Jake D, Chiang, Teresa P Y, Avery, Robin K, Karaba, Andrew H, Jefferis, Alexa, Warren, Daniel S, Massie, Allan B, Tobian, Aaron A R, Segev, Dorry L, Werbel, William A

“…Tixagevimab and Cilgavimab (T + C) is authorized for pre-exposure prophylaxis (PrEP) against Coronavirus Disease 2019 (COVID-19) in solid organ transplant…”
Get full text

Letter to the editor: “hook” (prozone) effect in sars‐cov‐2 anti‐spike binding antibody levels following vaccination, infection, or monoclonal antibody in solid organ transplant recipients by Abedon, Aura T., Chiang, Teresa P. Y., Karaba, Andrew H., Alejo, Jennifer L., Chahoud, Margaret, Hussey, Casey, Lopes, Jessica F., Hussain, Sarah, Larsen, Christian P., Durand, Christine M., Heeger, Peter S., Segev, Dorry L., Clarke, William A., Werbel, William A.

“…Anti-spike binding antibody (Ab) levels are used by some providers to inform COVID-19 risk assessment for solid organ transplant recipients (SOTRs). As has…”
Get full text

Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA‐1273 as a third dose in solid organ transplant recipients seronegative after two‐dose mRNA vaccination by Chiang, Teresa PY, Alejo, Jennifer L., Mitchell, Jonathan, Kim, Jake D., Abedon, Aura T., Karaba, Andrew H., Thomas, Letitia, Levan, Macey L., Garonzik‐Wang, Jacqueline M., Avery, Robin K., Pekosz, Andrew, Clarke, William A., Warren, Daniel S., Tobian, Aaron A. R., Massie, Allan B., Segev, Dorry L., Werbel, William A.

“…Heterologous vaccination (“mixing platforms”) for the third (D3) dose of SARS‐CoV‐2 vaccine is a potential strategy to improve antibody responses in solid…”
Get full text

Antibody response to 2‐dose SARS‐CoV‐2 mRNA vaccination in pediatric solid organ transplant recipients by Qin, Caroline X., Auerbach, Scott R., Charnaya, Olga, Danziger‐Isakov, Lara A., Ebel, Noelle H., Feldman, Amy G., Hsu, Evelyn K., McAteer, John, Mohammad, Saeed, Perito, Emily R., Thomas, Ashley M., Chiang, Teresa P. Y., Garonzik‐Wang, Jacqueline M., Segev, Dorry L., Mogul, Douglas B.

Get full text

Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients by Mitchell, Jonathan, Chiang, Teresa P-Y., Alejo, Jennifer L., Chang, Amy, Abedon, Aura T., Avery, Robin K., Tobian, Aaron A. R., Massie, Allan B., Levan, Macey L., Warren, Daniel S., Garonzik-Wang, Jacqueline M., Segev, Dorry L., Werbel, William A.

Get full text

Improved Antibody Response After a Fifth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series by Abedon, Aura T., Teles, Mayan S., Alejo, Jennifer L., Kim, Jake D., Mitchell, Jonathan, Chiang, Teresa P. Y., Avery, Robin K., Tobian, Aaron A. R., Levan, Macey L., Warren, Daniel S., Massie, Allan B., Garonzik-Wang, Jacqueline M., Segev, Dorry L., Werbel, William A.

Get full text

mTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to SARS‐CoV‐2 mRNA vaccines in solid organ transplant recipients by Bae, Sunjae, Alejo, Jennifer L., Chiang, Teresa P. Y., Werbel, William A., Tobian, Aaron A. R., Moore, Linda W., Guha, Ashrith, Huang, Howard J., Knight, Richard J., Gaber, A. Osama, Ghobrial, R. Mark, McAdams‐DeMarco, Mara A., Segev, Dorry L.

“…A recent study concluded that SARS‐CoV‐2 mRNA vaccine responses were improved among transplant patients taking mTOR inhibitors (mTORi). This could have…”
Get full text

Incidence and Severity of COVID-19 Among Vaccinated Solid Organ Transplant Recipients During the Omicron Wave by Alejo, Jennifer L., Chiang, Teresa P.Y., Bowles Zeiser, Laura, Kim, Jake D., Mitchell, Jonathan, Avery, Robin K., Tobian, Aaron A. R., Abedon, Rivka R., Levan, Macey L., Warren, Daniel S., Garonzik-Wang, Jacqueline M., Massie, Allan B., Segev, Dorry L., Werbel, William A.

Get full text

Incidence of SARS‐CoV‐2 infection among unvaccinated US adults during the Omicron wave by Alejo, Jennifer L., Chiang, Teresa P. Y., Mitchell, Jonathan, Abedon, Aura T., Jefferis, Alexa A., Werbel, William, Massie, Allan B., Makary, Martin A., Segev, Dorry L.

Get full text

Six-month Antibody Kinetics and Durability After 3 Doses of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series by Abedon, Aura T., Alejo, Jennifer L., Kim, Jake D., Thomas, Letitia, Mitchell, Jonathan, Chiang, Teresa P. Y., Avery, Robin K., Tobian, Aaron A. R., Levan, Macey L., Warren, Daniel S., Massie, Allan B., Garonzik-Wang, Jacqueline M., Segev, Dorry L., Werbel, William A.

Get full text